OVP has led the drive into new, high-growth technology markets in the Pacific Northwest for over 24 years. OVP's strategy of focusing on early stage investments in defined spaces has yielded proven results; the firm's record of 52 liquidity events - including 22 IPOs - leads the region. The OVP team has a passion for working with ground-breaking entrepreneurs and high-caliber investors, and is known for its track record and personal integrity. OVP has over $750 million in capital under management and is currently investing its seventh fund. OVP has offices in Seattle and Portland and concentrates on opportunities at the intersection of technology's next big waves and the foundational strengths native to the region. The firm's recent investments have been in communications, software, security, semiconductors, digital biology, and nanotechnology.

 

The OVP team includes investing partners Chad Waite, Lucinda Stewart, Mark Ashida, Rick LeFaivre and Carl Weissman in Seattle and Gerry Langeler, Dave Chen and John Hull in Portland. Chad Waite serves on the Board of the National Venture Capital Association (NVCA).

Monitor Ventures is an early-stage venture capital firm that partners with exceptional entrepreneurs to commercialize technology into world-class products and services.

 

Founded in 2002, the Firm leverages the investment, operating and entrepreneurial experience of its partners with its privileged access to the resources of the Monitor Group to accelerate portfolio companies path to customers, capital and profitability

Tech Coast Angels (TCA) is the largest U.S. angel investor network, provides funding and guidance to most early-stage companies in Southern California. Since 1997, TCA members have invested $58 million in 91 companies and have leveraged these investments into more than $552 million in venture co-investment for TCA portfolio companies. TCA offers not only capital, but also mentoring, recruiting help, and access to investors and partners. TCA has more than 270 members in its four networks in Los Angeles, Orange County, San Diego and Westlake.

Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on biotechnology and medical device companies. It was established by senior life science executives and experienced angel investors to meet the need for seed and early stage funding for life science companies that is often not available from venture capitalists or individual investors. By identifying promising investment opportunities and bringing together members who add sector-specific experience, broad networks, and financial backing, Life Science Angels is able to assist emerging companies to position themselves for later-round venture-backed funding.